Momenta Pharma

Cambridge, United States Founded: 2001 • Age: 25 yrs Listed Acquired By Johnson & Johnson
Novel therapies for rare immune-mediated diseases are developed.

About Momenta Pharma

Momenta Pharma is a Healthcare company based in Cambridge (United States) founded in 2001 by Christoph Westphal and Robert Langer, and was acquired by Johnson & Johnson in August 2020. Novel therapies for rare immune-mediated diseases are developed. Momenta Pharma has raised $39.5 million across 2 funding rounds from investors including Johnson & Johnson, Atlas Venture and MVM Partners. The company has 134 employees. Its focus areas include Traditional Pharmaceuticals and Diversified.

Company details

Momenta was founded in 2001 in Cambridge, United States, within the biotechnology sector. Research and development activities are centered on treatments for rare immune-mediated diseases. New therapeutic approaches are identified and advanced through pre-clinical and clinical stages to meet unmet medical needs. Operations emphasize innovative solutions for these conditions, with co-founders including Christoph Westphal and Robert Langer.

  • Headquarters Cambridge, United States
  • Employees 134
  • Founders Christoph Westphal, Robert Langer
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website momentapharma.com
  • Social LinkedIn X
  • Acquired by Johnson & Johnson (Aug 2020)
Key Metrics
  • Annual Revenue
    $23.87 M (USD)
    -68
    as on Dec 31, 2019
  • EBITDA
    -$298.09 M (USD)
    -64
    as on Dec 31, 2019
  • Total Equity Funding
    $39.5M (USD)

    in 2 rounds

  • Latest Funding Round
    $20.5M (USD), Series C

    Mar 2004

  • Investors
  • Employee Count
    134
  • Acquired by

Funding Insights of Momenta Pharma

Momenta Pharma has successfully raised a total of $39.5M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $20.5 million completed in March 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $39.5M
  • Total Rounds 2
  • Last Round Series C β€” $20.5M
  • First Round $19M

    (May 2003)

  • Investors Count 4

All 2 funding rounds of Momenta Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2004$20.5MSeries C––
May 2003$19MSeries B–Atlas Venture, MVM
Valuation history

5 investors in total: 5 institutional.

Investors in Momenta Pharma

Momenta Pharma has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Johnson & Johnson, Atlas Venture and MVM Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
US focused venture capital firm
polarispartners.comBoston, United States
Venture capital firm investing in life science and biotechnology sectors
1980atlasventure.comCambridge, United States
Life science & tech focused VC firm investing in early stage companies in the US
cardinalpartners.comPrinceton, United States
Private equity investments in healthcare companies are managed.
1997mvm.comLondon, United Kingdom
Healthcare solutions are provided by Johnson & Johnson globally.
1886jnj.comNew Brunswick, United States
Premium access

Investor details for Momenta Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Momenta Pharma

2 people are tracked at Momenta Pharma (2 in leadership); the tracked headcount is 134.

NameRoleGroup
Christoph Westphal
Co-FounderLeadership
Robert Langer
Co-FounderLeadership
Premium access

Complete people profiles for Momenta Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Momenta Pharma

5 dated milestones of Momenta Pharma across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Momenta Pharma is founded.
  2. Funding First funding round of $19.0M.
  3. Funding Latest funding round, Series C, of $20.5M.
  4. IPO Lists on the stock exchange (IPO).
  5. Exit Acquired by Johnson & Johnson.

Web traffic of Momenta Pharma

Websites that share an audience with Momenta Pharma (momentapharma.com).

  • Global rank
    #11,284,544

    among all websites

  • Category rank
    #8,084

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Momenta Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
proteontherapeutics.com
100%
View details
genzyme.com
94%
View details
celgene.com
94%
View details
tevapharm.com
92%
166.9K#278,209View details
zafgen.com
92%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 15 similar websites and full traffic analytics for Momenta Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Momenta Pharma (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Momenta Pharma

Momenta Pharma was founded in 2001 and raised its 1st funding round 2 years after it was founded.

Momenta Pharma is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Momenta Pharma is a funded company, having raised a total of $39.5M across 2 funding rounds to date. The company's 1st funding round was a Series B of $19M, raised on May 2003.

Momenta Pharma has 134 employees.

Annual revenue of Momenta Pharma is $23.87M as on Dec 31, 2019.

Momenta was founded in 2001 in Cambridge, United States, within the biotechnology sector. Research and development activities are centered on treatments for rare immune-mediated diseases. New therapeutic approaches are identified and advanced through pre-clinical and clinical stages to meet unmet medical needs. Operations emphasize innovative solutions for these conditions, with co-founders including Christoph Westphal and Robert Langer.

Momenta Pharma has 5 investors. Key investors include Johnson & Johnson, Atlas Venture, MVM Partners, Polaris Partners, and Cardinal Partners.

Yes. Momenta Pharma was acquired by Johnson & Johnson in August 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available